VTGN is Vistagen Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.25. Market cap: $11M. Capital Quality Rank: 31/100 — Stagnant mediocrity.
Stock snapshot
| Price | $0.25 |
| Market cap | $11M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 31 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -1204.4% |
| Shareholder buyback yield | -18.90% |
| Altman Z-score zone | Distress |
About VTGN
Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.
Related non-dividend companies
Other non-dividend stocks investors research alongside VTGN. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VTGN's current stock price?
VTGN (Vistagen Therapeutics, Inc.) is currently trading at $0.25.
Does VTGN pay a dividend?
VTGN (Vistagen Therapeutics, Inc.) does not currently pay a regular dividend.
What is VTGN's Capital Quality Rank?
VTGN has a Capital Quality Rank of 31/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track VTGN in DiviDrip
Add VTGN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VTGN and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.